4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-082804
Chief Scientific Officer sold 1,100 shares at $20.00 ($22,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reich Kristian Chief Scientific Officer | 2026-07-27 | Sale 10b5-1 | −1,100 | $20.00 | $22,000 | 2,711,198 | I |
| Open-market sales · 1,100 sh · avg $20.00 · $22,000 | |||||||
Loading xslF345X06/ownership.xml…